Investor
Also: NeuroFlow teams up with the Independence Blue Cross Foundation and Trinity Health Mid-Atlantic to provide its mental health software to frontline healthcare workers.
Kintsugi says that its vocal biomarker tech can detect depression and anxiety from 20 seconds of freeform speech.
The new acquisition is set to give K Health more behavioral health capabilities.
Also: Better Therapeutics scored a $50 million loan facility, DiA Imaging Analysis raised $14 million and SCAN Group invested in MedArrive.
Ginger’s CEO Russell Glass will take over as CEO of Headspace Health, and Headspace CEO CeCe Morken will continue to serve as Headspace CEO and president of the combined company.
The platform lets patients with rare diseases access their medical data and participate in research studies.
Connect America signed a definitive agreement to acquire 100Plus for an undisclosed sum.
Funding will be used towards scaling the platform, focusing on product development and expansion across the Kingdom and the rest of the GCC region.
Venture capital and private equity firm Insight Partners led the round with participation from existing investors including Equity Group Investments.
Also: Opya scooped up $15.4 million, MiSalud raised $5 million and DocSpace announced $1.2 million in seed funding.